Ishami Mpuzamahanga

Mu ntangiriro za Werurwe, Ikigo cy’Igihugu gishinzwe Ibikoresho by’Ubuvuzi cyemeje Jaypirca® (pirtobrutinib) ku barwayi bakuru barwaye kanseri y’urukende idakira (CLL) cyangwa kanseri y’urukende nto (SLL) bahawe nibura ubuvuzi bumwe mbere, harimo na Bruton's tyrosin...Soma byinshi»

Amakuru ashimishije aherutse kugaragara mu Kigo gishinzwe Isuzuma ry’Imiti (CDE) cy’Ikigo cy’Igihugu gishinzwe Ibikoresho by’Ubuvuzi mu Bushinwa: igeragezwa rya KSD-101 Injection, ryakozwe na Hensen Bio, ryemejwe. Ikoreshwa ryagaragajwe ni iry’ “Ibibyimba by’amaraso bifitanye isano na EBV bifite…Soma byinshi»

Vuba aha, Ikigo cy’Igihugu cy’Ubushinwa gishinzwe Ibikoresho by’Ubuvuzi (NMPA) cyemeje ikimenyetso gishya cya Bireociclib, umuti mushya wo mu cyiciro cya mbere wakozwe ku giti cyawo na Xuanzhu Biopharmaceutical. Iki kimenyetso gishya ni icyo gukoreshwa hamwe n’umuti ubuza aromatase nk’uburyo bwa mbere bwo kuvura indwara z’imisemburo (endocrine therapy) ...Soma byinshi»

Ku ya 28 Gashyantare 2026, Ikigo cy'Igihugu gishinzwe Ibikoresho by'Ubuvuzi (NMPA) cyemeje ku mugaragaro kwamamaza JMKX001899 sulfate mu kuvura abarwayi bakuru barwaye kanseri y'ibihaha ya KRAS G12C-mutated advanced non-small cell (NSCLC) bamaze nibura guhabwa ubuvuzi bumwe mbere. JMKX00189...Soma byinshi»

Ku ya 13 Gashyantare 2026, Ikigo gishinzwe Isuzuma ry'Imiti (CDE) cy'Ikigo cy'Igihugu gishinzwe Ibikoresho by'Ubuvuzi mu Bushinwa cyatangaje ko ibinini bya GFH375 byashyizwe mu cyiciro cya Breakthrough Therapy Designation cyo kuvura abarwayi ba kanseri y'ibihaha ya KRAS G12D-mutant non-small cell cancer (NSCLC) ...Soma byinshi»

Ku ya 12 Gashyantare 2026, Ikigo cy’Isuzuma ry’Imiti (CDE) cy’Ikigo cy’Igihugu gishinzwe Ibikoresho by’Ubuvuzi mu Bushinwa cyatangaje ku ya 4 Gashyantare ko umuti wa ENHERTU® (trastuzumab deruxtecan) watanzweho igitekerezo cyo gushyirwa muri Gahunda yo Gutanga Ubuvuzi bw’Iterambere kugira ngo ukoreshwe nk’ubuvuzi bwunganira abarwayi bakuru bafite HER2...Soma byinshi»

Ishami Mpuzamahanga ry’Ibitaro bya Oncology byo mu Karere k’Amajyepfo rya Beijing ritewe ishema no guha abarwayi mpuzamahanga uburyo bwo kuvura kanseri bugezweho, harimo n’ubuvuzi bwa Boron Neutron Capture Therapy (BNCT) – uburyo bushya bwo kuvura bwamaze guhindura ubuzima. Ikimenyetso cy’ubuzima nyakuri: Urugendo rwa Madamu Wu muri 2022...Soma byinshi»

Ku ya 9 Gashyantare 2026, urubuga rwemewe rw'Ikigo gishinzwe Isuzuma ry'Imiti (CDE) cy'Ikigo cy'Igihugu gishinzwe Ibikoresho by'Ubuvuzi (NMPA) rwatangaje ko ZL-1310 yo guterwa inshinge, umuti mushya uhuriweho n'imiti irwanya DLL3 (ADC), uteganijwe guhabwa urwego rwo kuvura indwara. Nk'umukiriya...Soma byinshi»

Ku murwayi wese ukora urugendo rurerure agiye gushaka ubuvuzi bwacu, turabyumva neza: icyo uzanye si inyandiko z’ubuvuzi zigoye gusa ahubwo ni n’icyizere n’ibyiringiro by’umuryango wawe wose. Mu ishami mpuzamahanga ry’ibitaro bya Beijing Region South Oncology Hospital, tubona inkuru nk’izo buri munsi—ho...Soma byinshi»

Mu gihe duhanganye n'ikibazo cyo kuvura kanseri y'inkondo y'umura ya HER2, turasobanukiwe neza icyifuzo cyawe cyihutirwa cyo kuvura neza kandi mu buryo bugezweho. Uyu munsi, tuzanye amakuru akomeye atera inkunga aturutse mu rwego rw'ubuvuzi bwa kanseri mu Bushinwa. **Ubuvuzi bugezweho buri hafi kugerwaho: SHR-A1811 yagaragaje ko ari umwihariko...Soma byinshi»

Vuba aha, Ikigo cy'Igihugu gishinzwe Ibikoresho by'Ubuvuzi mu Bushinwa cyemeye ku mugaragaro uburyo bwo kuvura Anlotinib Hydrochloride na Penpulimab bwakozwe na Chia Tai Tianqing mu rwego rwo kuvura kanseri y'umwijima iteye imbere. Iki ni ikimenyetso cya cumi cyemewe cya Anlotinib Hyd...Soma byinshi»

Vuba aha, urwego rw'ubuvuzi bwa kanseri mu Bushinwa rwageze ku ntambwe ikomeye. Ku ya 7 Mutarama 2025, Ikigo cy'Igihugu gishinzwe Ibikoresho by'Ubuvuzi cyemeye ku mugaragaro umuti mushya SHR-1701 kugira ngo ukoreshwe ku isoko. Ugaragazwa hamwe na chimiotherapie nk'uburyo bwa mbere bwo kuvura kanseri ku...Soma byinshi»